乙型肝炎病毒3‘末端缺失的preS／S基因在转基因小鼠中的表达

从乙型肝炎病毒ａｄｒ亚型的基因组ＤＮＡ中分离３’末端缺失的ｐｒｅＳ／Ｓ基因的ＤＮＡ片段,构建了由ＣＭＶ启动子控制的真核表达载体。采用受精卵显微注射方法,获得了基因组整合有３’末端缺失的ｐｒｅＳ／Ｓ基因的２个转基因小鼠品系。在不同的时间点采取血清进行了ＥＬＩＳＡ分析,发现在这２个小鼠品系中３’末端缺失的ｐｒｅＳ／Ｓ基因可被表达,而且呈稳定状态。此小鼠品系的建立,对于探讨乙型肝炎病毒３’末端缺失的ｐｒ     

乙型肝炎病毒3′末端缺失的preS/S基因在转基因小鼠中的表达

从乙型肝炎病毒adr亚型的基因组DNA中分离3′末端缺失的preS/S基因的DNA片段,构建了由CMV启动子控制的真核表达载体。采用受精卵显微注射方法,获得了基因组整合有3′末端缺失的preS/S基因的2个转基因小鼠品系。在不同的时间点采取血清进行了ELISA分析,发现在这2个小鼠品系中3′末端缺失的preS/S基因可被表达,而且呈稳定状态。此小鼠品系的建立,对于探讨乙型肝炎病毒3′末端缺失的preS/S基因的表达产物在体内的生物学作用及其与肝细胞内细胞癌基因的转录激活之间的关系有重要意义。     

HBV整合片段对人PCNA基因启动子的调控

Ｈ７Ｃ是从一例肝癌组织中克隆得到的ＨＢＶ整合片段,其中保留有ｐｒｅＳ２基因的启动子及Ｃ端缺失的ｐｒｅＳ／Ｓ蛋白的阅读框架,我们用共转染方法研究了该整合片段地增殖细胞核抗原启动子的影响。结合表明在ＨｅｐＧ２细胞中,含有上述ＨＢＶ整合片段ＤＮＡ的质粒ＰＫＳＨ７Ｃ－ＨｐａＩ能以剂量依赖方式激活ＰＣＮＡ启动子。对ＳＶ４０启动子而言,ＰＣＮＡ启动子有１－２倍的更高激活。而破坏ｐｒｅＳ／Ｓ表达的两个亚克隆ＰＫ     

小鼠巢蛋白基因结构及其转录调控元件的初步鉴定

通过筛选小鼠基因组ＢＡＣ文库,得到小鼠巢蛋白基因组２３．３ｋｂ ＤＮＡ序列,其中约１５．３ｋｂ已完成测序。与小鼠ｃＤＮＡ序列比较结果表明,小鼠巢蛋白基因包含３个内含子。与大鼠及人巢蛋白基因相比,小鼠巢蛋白基因中３个内含子的位置及大小均很保守。利用神经发育的体外实验模型,检测小鼠巢蛋白基因第２个内含子对荧光素酶报告基因的调控活性。系列缺失质粒转染细胞显示,小鼠巢蛋白基因第２个内含子对报告基因的转录具     

表达乙肝病毒包膜中蛋白的嗜甲醇毕赤酵母菌株的构建

巴斯德毕赤酵母是一种很有潜力的真核表达体系。本文报告将已克隆的乙型肝炎病毒ｐｒｅＳ２－Ｓ基因亚克隆于巴斯德毕赤酵母胞内表达质粒ｐＰＩＣ３,构建重组ｐＰＩＣ３／ｐｒｅＳ２－Ｓ质粒,经酶切线性化后,将其用电转化导入酵母细胞内,经ＰＣＲ及ｄｏｔｂｌｏｔ检测,挑选出在染色体上稳定整合了乙肝病毒包膜中蛋白编码基因的嗜甲醇毕赤酵母菌株,为高效表达乙肝病毒包膜中蛋白奠定了基础     

人乙型肝炎病毒前表面抗原（preS）基因的突变及其在家蚕细胞中影响 …

为探讨人乙型肝炎病毒（ＨＢＶ）前表面抗原（ｐｒｅＳ）基因的表达调控机理,以实现高效表达,利用ＰＣＲ方法在克隆的ｐｒｅＳ基因的第２、３位密码子引入同义突变。消除存在于５端编码区保守的反向重复序列,将ｐｒｅＳ基因及其突变形式（ＭｐｒｅＳ）分别重组到转移载体ｐＢＭ０３０,获得ｐＢＭ－ｐｒｅＳ和ｐＢＭ－ＭｐｒｅＳ。将ｐＢＭ－ｐｒｅＳ和ｐＢＭ－ＭｐｒｅＳ分别与野生型家蚕核型多角体病毒（ｂｍＮＰＶ）ＤＮＡ共转     

BALB／c等小鼠线粒体DNAD环区PCR—SSCP分析

用ＰＣＲ－ＳＳＣＰ方法分析ＢＡＬＢ／ｃ等７个近交系小鼠线粒体ＤＮＡ（ｍｔＤＮＡ）的多态性,探讨其遗传起源及亲缘关系,结果发现,这些小鼠ｍｔＤＮＡ的高变异性区,Ｄ－ｌｏｏｐ ５’及３’端的ＳＳＣＰ电泳带型完全相同,未发现多态性。表明ＴＡ２、６１５、Ｔ７３９、ＢＡＬＢ／ｃ、Ｃ３Ｈ、Ｃ５７ＢＬ／６Ｊ、ＤＢＡ／２等近交系小鼠的ｍｔＤＮＡ具有高度的同源性。     

丙肝病毒融合抗原基因NS3-C定点整合入衣藻叶绿体基因组的研究

用ＰＣＲ 方法从丙型肝炎病毒（ＨＣＶ） ｃＤＮＡ 文库中克隆了两段ＤＮＡ 片段,即ＨＣＶ 基因组非结构ＮＳ３区抗原基因（约０．７ ｋｂ）和核心抗原Ｃ区抗原基因（约０．６ ｋｂ）的ｃＤＮＡ 片段。在两段ｃＤＮＡ 间加入连接肽Ｓｅｒ－ Ｐｒｏ－ Ｇｌｙ－ Ｓｅｒ 的密码子序列,构建成融合抗原基因ＮＳ３－ Ｃ。将该融合基因与衣藻叶绿体基因ａｔｐＡ 的启动子和ｒｂｃＬ 基因的３′末端连接,得到丙肝病毒融合抗原基因ＮＳ３－ Ｃ表达盒,再将该表达盒与选择标记基因ａａｄＡ 表达盒和衣藻叶绿体基因组同源片段连接,构建成衣藻叶绿体转化载体ｐＳＳ６。基因枪法转化衣藻叶绿体,经壮观霉素筛选获得转化再生的单藻落,对转基因衣藻的ＰＣＲ 和Ｓｏｕｔｈｅｒｎ 杂交分析表明,融合抗原基因ＮＳ３－ Ｃ已整合到衣藻叶绿体基因组中。     

人生长激素基因逆转录病毒载体的构建及其对3T3和ES细胞的转化与表达

为了研究生长激素基因在异源细胞中的表达,构建了携带人生长激素基因（ｈＧＨ）的逆转录病毒载体ｐＩＮＳ－ＧＨ,并将其导入小鼠成纤维细胞３Ｔ３和小鼠胚胎干细胞（ＥＳ细胞）ＣＣＥ中。ｐＩＮＳ－ＧＨ转化３Ｔ３细胞,获得了高效表达的克隆,即用放射免疫法检测到克隆培养基中有大量的人生长激素蛋白富积,如ＧＨＳＮＣ２０,富积率高达３７８４ｎｇ／ｍｌ,而且外源基因的整合很稳定。不同的３Ｔ３转化克隆的表达率有显著的差异,Ｓｏｕｔｈｅｒｎ杂交的结果表明,这种差异与外源基因整合的拷贝数无关。ｐＩＮＳ－ＧＨ转化ＣＣＥ细胞没有获得明显表达的克隆,而且外源基因的整合也不稳定。转化的ＥＳ细胞克隆总ＤＮＡ的Ｓｏｕｔｈｅｒｎ杂交结果表明,ｈＧＨ基因的确整合到细胞基因组中。目前尚未发现明显的外源ＤＮＡ重排的迹象。     

矮牵牛花同源异型基因fbp2的克隆及其对烟草花形态的影响

以矮牵牛（Ｐｅｔｕｎｉａ　ｈｙｂｒｉｄａ　Ｌ．）栽培品种为材料,取开放前的花蕾分离ｍＲＮＡ,反转录合成ｃＤＮＡ,以ｃＤＮＡ为模板,通过ＰＣＲ扩增,对获得的目的片段进行序列分析。结果表明,分离的目的片段含有６８６个核苷酸（含有起始密码和终止密码）。核苷酸序列与文献报道相比,同源率为９９．６％,只有３个碱基发生改变,５’端的ＭＡＤＳ盒区域完全相同。将得到的矮牵牛花同源异型基因ｆｂｐ２的ｃＤＮＡ（ｙｆｂｐ２）与ＣａＭＶ３５５启动子和ＮＯＳ３’终止子融合,构建了表达载体ｐＢＢＰ２。表达载体通过农杆菌（Ａｇｒｏｂａｃｔｅｒｉｕｍ　ｔｕｍｅｆａｃｉｅｎｓ）ＬＢＡ４４０４（ｐＡＬ４４０４）介导转化烟草（ＮｉｃｏｔｉａｎａｔａｂａｃｕｍＬ．）叶片,在含有１００ｍｇ／Ｌ卡那霉素的抗性培养基上再生成株。对抗性株进行总ＤＮＡＳｏｕｔｈｅｒｎ杂交和总ＲＮＡ的点杂交,证明目的基因已导入烟草细胞中,整合到烟草基因组上,并且在烟草细胞中转录。同源异型基因ｆｂｐ２导入烟草后导致烟草花型改变,在雄蕊上产生了花瓣。     

HBV preS/S基因克隆及其在酿酒酵母中的表达

目的:探索利用酿酒酵母系统表达乙型肝炎病毒(HBV)preS／S基因。方法:利用PCR技 术,以HBV病毒DNA为模板,体外扩增HBV preS／S基因。然后构建重组表达载体pESC-preS／S。 用LiAc法转化酿酒酵母YPH50,选取重组菌进行培养,并诱导表达外源蛋白。提取蛋白浓缩后 进行SDS-PAGE分析,并经Western blot分析鉴定。结果:实验结果表明重组菌能够表达HBV preS／S蛋白。结论:利用酿酒酵母系统可成功表达HBV preS／S基因,为制备新型预防性疫苗提供 条件。     

乙型肝炎病毒蛋白和绿色荧光蛋白的共表达研究

目的：构建增强型绿色荧光蛋白（EGFP）标记的乙型肝炎病毒（HBV）真核表达载体,并研究其在真核细胞和小鼠体内的共表达。方法：以质粒pBR322-HBVadr2．0和pCX-EGFP为基础,构建含有双拷贝HBV全基因组DNA和EGFP基因的真核表达载体pCX-EGFP-HBVadr2．0,分别转染真核细胞和小鼠肝组织,建立体外、体内表达系统,研究GFP和HBV基因的表达。结果：构建了真核表达载体pCX-EGFP-HBVadr2．0,EGFP和HBV病毒蛋白在体内和体外均可表达。结论：构建的pCX-EGFP-HBVadr2．0真核表达载体可以GFP作为HBV存在与否的报告基因,提高了培育检测转基因小鼠的效率,为转基因小鼠的制备及后续研究奠定了基础。     

Immunogenicity of recombinant hepatitis B virus surface antigen fused with preS1 epitopes expressed in rice seeds

To test the possibility of producing a novel hepatitis B vaccine in plants, the modified hepatitis B virus (HBV) surface antigen (HBsAg) gene SS1 was expressed in rice under the control of the seed-specific Glub-4 promoter. The SS1 gene encodes a fusion protein consisting of amino acids 21-47 of the hepatocyte receptor-binding presurface 1 region (preS1) fused to the truncated C-terminus of the major HBV surface (S) protein. The production of antibodies against the preS1 region acts to protect humans against HBV infection by preventing HBV from binding to hepatocytes. The presence of SS1 in the genome of transgenic rice was confirmed by PCR and Southern blot analysis, and RNA dot blot analysis indicated that the fused SS1 gene was specifically expressed in rice seeds, with the highest expression level being about 31.5 ng/g dry weight grain. Western blot analysis revealed that the recombinant SS1 protein could be specifically recognized by both an anti-S protein antibody and an anti-preS1 antibody. The recombinant SS1 protein was also observed to form virus-like particles with a diameter of about 22 nm and a density of 1.25 g cm(-3). Furthermore, immunological responses against both the S and preS1 epitopes were induced in BALB/c mice immunized with the recombinant SS1 protein, indicating that this rice-derived SS1 protein could be a promising candidate as an alternative HBV vaccine for preventing hepatitis B.     

A modified hepatitis B surface antigen carrying both preS1 and preS2 epitopes

ＴｈｅｅｎｖｅｌｏｐｅｐｒｏｔｅｉｎｏｆｈｅｐａｔｉｔｉｓＢｖｉｒｕｓ(ＨＢＶ)ｃｏｎｓｉｓｔｓｏｆｔｈｒｅｅｐｒｏｔｅｉｎｓ:ｓｍａｌｌ(Ｓ),ｍｉｄｄｌｅ(Ｍ)ａｎｄｌａｒｇｅ(Ｌ)[1].ＴｈｅＳｐｒｏｔｅｉｎｃａｒｒｉｅｓａｌｌｔｈｅｉｎｆｏｒｍａｔｉｏｎｒｅｑｕｉｒｅｄｆｏｒｃｅｌｌｕｌａｒｌｉｐｉｄｓｍｏｂｉｌｉｚａｔｉｏｎ,ｓｕｂｖｉｒａｌｐａｒｔｉｃｌｅｆｏｒｍａｔｉｏｎａｎｄｓｅｃｒｅｔｉｏｎ.Ｉｔｈａｓｂｅｅｎｓｕｃｃｅｓｓｆｕｌｌｙｄｅｖｅｌｏｐｅｄａｓａｃａｒｒｉｅｒｔｏｅｘｐｒｅｓｓｆ…     

Expression and purification of the synthetic preS1 gene of Hepatitis B Virus with preferred Escherichia coli codon preference

To produce high levels of hepatitis B virus (HBV) preS1 protein at low cost, a DNA fragment encoding the preS1 region, residues 1-119, of HBV adr subtype was synthesized by overlapping-PCR according to Escherichia coli (E. coli) B preferred codon usage. The synthetic preS1 gene (spreS1) was cloned into the bacterial expression vector pET-30a and transferred into the expression strain E. coli BL21(DE3). Recombinant preS1 protein with an N-terminal His6 tag was expressed at high levels in soluble form, yielding about 44% of the total cellular protein. This technique overcomes problems that existed in previously reported expression systems of preS1 or its epitope, i.e., low-level expression or expression in inclusion bodies. Using this His-tagged preS1 expression system, recombinant protein was purified by single-step affinity chromatography on a Ni-NTA column resulting in a yield was about 28 mg recombinant protein per liter culture. Furthermore, Western blotting and indirect ELISA analysis demonstrate that the reactivity of preS1-specific antibody is comparable between the recombinant and commercialized preS1 protein. Thus, our improved expression system could be used for practical, low-cost large-scale production of recombinant preS1 without refolding steps.     

Genotyping of hepatitis B virus in Malaysia based on the nucleotide sequence of preS and S genes

Hepatitis B virus (HBV) has been classified into eight genotypes, designated A-H. These genotypes are known to have distinct geographic distributions. The clinical importance of genotype-related differences in the pathogenicity of HBV has been revealed recently. In Malaysia, the current distribution of HBV remains unclear. The aim of this study was to determine the genotypes and subtypes of HBV by using PCR, followed by DNA sequencing, as well as to analyse the mutations in the immunodominant region of preS and S proteins. The S gene sequence was determined from HBV DNA of four apparently healthy blood donors' sera and three sera from asymptomatic chronic hepatitis B carriers. Of this batch of sera, the preS gene sequence was obtained from HBV DNA from three out of the four blood donors and two out of the three chronic carriers. Due to insufficient sera, we had to resort to using sera from another blood donor to make up for the sixth DNA sequence of the preS gene. Based on the comparative analysis of the preS sequences with the reported sequences in the GenBank database, HBV DNA from two normal carriers was classified as genotype C. Genotype B was assigned to HBV from one blood donor and two hepatitis B chronic carriers, whereas HBV of one chronic carrier was of genotype D. Based on the S gene sequences, HBV from three blood donors was of genotype C, that of one blood donor and one chronic carrier was of genotype B, and the remaining, of genotype D. In the five cases where both preS and S gene sequences were determined, the genotypes assigned based on either the preS or S gene sequences were in concordance. The nature of the deduced amino acid (aa) sequences at positions 125, 127, 134, 143, 159, 161 and 168 of the S gene enabled the classification of these sequences into subtypes, namely, adrq+, adw2 and ayw2. The clustering of our DNA sequences into genotype groups corresponded to their respective subtype, that is, adw2 in genotype B, adrq in genotype C and ayw in genotype D. Analysis of the point mutations revealed that five of the sequences contained aa substitutions at immunodominant epitopes involved in B or/and T cell recognition. In conclusion, despite the low numbers of samples studied, due to budget constraints, these data are still worthwhile reporting, as it is important for the control of HBV infections. In addition, the genotype and mutational data obtained in this study may be useful for designing new treatment regimes for HBV patients.     

转基因植物高效删除标记基因的实用型双元转化载体

利用雌激素诱导的Cre/loxPDNA重组系统,构建用于转基因植物删除标记基因的实用新型载体,将所有非目的基因放于两同向loxP位点间,多克隆位点位于两loxP位点外,可插入目的基因,载体设计非常实用。在插入目的基因GUS后转化烟草,雌激素诱导,分析诱导前后DNA的重组情况、不同时间基因转录水平,以及目的基因在诱导前后的表达。结果显示,诱导后染色体DNA实现了高效重组,非目的基因片段消失,目的基因GUS在诱导后表达正常。